Osteoarticular Manifestations of Antiphospholipid Syndrome

Rheumatic Disease Clinics of North America

Volumn 32, Issue 3, 2006, Pages 523-535

  Tektonidou, Maria G ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTHRITIS; BLEEDING; BONE NECROSIS; CLINICAL FEATURE; HEMOLYTIC ANEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTHRITIS; BONE DISEASES; EARLY DIAGNOSIS; JOINT DISEASES; OSTEONECROSIS;

EID: 33746379574     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2006.05.003     Document Type: Review

References (84)

1. Hughes G.R. The antiphospholipid syndrome: ten years on. Lancet 342 8867 (1993) 341-344
2. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46 4 (2002) 1019-1027
3. Weber M., Hayem G., de Bandt M., et al. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?. J Rheumatol 26 (1999) 2131-2136
4. Asherson R.A., Khamashta M.A., Ordi-Ros J., et al. "Primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68 6 (1989) 366-374
5. Piette J.C., Whechsler B., Francès C., et al. Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 20 10 (1993) 1802-1803
6. Queyrel V., Hachula E., and Cardon T. Arthritis in primary antiphospholipid syndrome?. J Rheumatol 23 7 (1996) 1305
7. Piette J.C., and Asherson R.A. Arthritis in primary antiphospholipid syndrome?. Reply. J Rheumatol 23 7 (1996) 1305-1306
8. Mankin H.J. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 326 22 (1992) 1473-1479
9. Phemister D.B. Fractures of the neck of the femur, dislocation of hip, and obscure vascular disturbances producing aseptic necrosis of the head of the femur. Surg Gynec Obstet 59 (1934) 415-440
10. Jones Jr. J.P., Sakovich L., and Anderson C.E. Experimentally produced osteonecrosis as a result of fat embolism. In: Beckman E.L., Elliott D.H., and Smith E.M. (Eds). Dysbarism-related osteonecrosis. HEW publ (NIOSH) 75-153 (1974), U.S. Government Printing Office, Washington (DC) 117-132
11. Boettcher W.G., Bonfiglio M., Hamilton H.H., et al. Nontraumatic necrosis of the femoral head. Relation of altered hemostasis to etiology. J Bone Joint Surg Am 52 2 (1970) 312-321
12. Glueck C.J., Glueck H.I., Greenfield D., et al. Protein C and S deficiency, thrombophilia and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease. Pediatr Res 35 4 Pt1 (1994) 383-388
13. Glueck C.J., Freiberg R., Tracy T., et al. Thrombophilia and hypofibrinolysis. Pathophysiologies of osteonecrosis. Clin Orthop 334 (1997) 43-56
14. Van Veldhuizen P.J., Neff J., Murphey M., et al. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 44 4 (1993) 243-248
15. Arruda V.R., Belangero W.D., Ozelo M.C., et al. Inherited risk factors for thrombophilia among children with Legg-Calve-Perthes disease. J Pediatr Orthop 19 1 (1999) 84-87
16. Glueck C.J., Crawford A., Roy D., et al. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg 78 1 (1996) 3-13
17. Balassa V.V., Gruppo R.A., Glueck C.J., et al. Legg-Calve-Perthes disease and thrombophilia. J Bone Joint Surg Am 86-A 12 (2004) 2642-2647
18. Herndon W.A. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg Am 79 7 (1997) 1114-1115
19. Tektonidou M.G., and Moutsopoulos H.M. Immunologic factors in the pathogenesis of osteonecrosis. Orthop Clin North Am 35 3 (2004) 259-263
20. Jones Jr. J.P. Intravascular coagulation and osteonecrosis. Clin Orthop 277 (1992) 41-53
21. Alijotas J., Argemi M., and Barquinero J. Kienbock's disease and antiphospholipid antibodies. Clin Exp Rheumatol 8 3 (1990) 297-298
22. Glueck C.J., McMahon R.E., Bouquot J.E., et al. The pathophysiology of idiopathic osteonecrosis of the jaws: thrombophilia and hypofibrinolysis. (abstract). J Invest Med 43 Suppl 2 (1995) 234A
23. Gruppo R., Glueck C.J., and McMahon R.E. The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia and hypofibrinolysis. J Lab Clin Med 127 5 (1996) 481-488
24. Korompilias A.V., Gilkeson G.S., Ortel T.L., et al. Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop 345 (1997) 174-180
25. Jones L.C., Mont M.A., Petri M., et al. Procoagulants and osteonecrosis. J Rheumatol 30 4 (2003) 783-791
26. Rademaker J., Dobro J.S., and Solomon G. Osteonecrosis and human immunodeficiency virus infection. J Rheumatol 24 3 (1997) 601-604
27. Gerster J.C., Camus J.P., Chave J.P., et al. Multiple site avascular necrosis in HIV infected patients. J Rheumatol 18 2 (1991) 300-302
28. Solomon G., Brancato L., and Winchester R. An approach to the human immunodeficiency virus positive patient with a spondyloarthropathic disease. Rheum Dis Clin North Am 17 1 (1991) 42-58
29. Chevalier X., Larget-Piet B., Hernigou P., et al. Avascular necrosis of te femoral head in HIV-infected patients. J Bone Joint Surg Br 75 1 (1993) 160
30. Belmonte M.A., Garcia-Portales R., Domenech I., et al. Avascular necrosis of bone in human immunodeficiency virus infection and antiphospholipid antibodies. J Rheumatol 20 8 (1993) 1425-1428
31. Molina J.F., Citera G., and Rosler D. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J Rheumatol 22 2 (1995) 347-350
32. Koeger A.C., Banneville B., Gerster J.C., et al. Avascular osteonecrosis in HIV-infected patients: 10 cases. (abstract 277). Arthritis Rheum 38 Suppl (1995) S119
33. Olive A., Queralt C., Sirera G., et al. Osteonecrosis and HIV-infection: 4 more cases. J Rheumatol 25 6 (1998) 1243-1244
34. Calza L., Manfredi R., and Chiodo F. Osteonecrosis in HIV-infected patients and its correlation with highly active antiretroviral therapy (HAART). Presse Med 32 13 Pt 1 (2003) 595-598
35. Miller K.D., Masur H., Jones E.C., et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 137 1 (2002) 17-25
36. Stimmler M.M., Quismorio F.P., McGehee W.G., et al. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 149 8 (1989) 1833-1835
37. Coll Daroca J., Gutierrez-Cebollada J., Yazbeck H., et al. Anticardiolipin antibodies and acquired immunodeficiency syndrome. Prognostic marker or association with HIV infection. Infection 20 3 (1992) 140-142
38. Llauger J., Palmer J., Roson N., et al. Osteonecrosis of the knee in an HIV-infected patient. AJR Am J Roentgenol 171 4 (1998) 987-988
39. Johns D.G., and Gill M.J. Avascular necrosis in HIV infection. AIDS 13 14 (1999) 1997-1998
40. Monier P., McKown K., and Bronze M.S. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clin Infect Dis 31 6 (2000) 1488-1492
41. Asherson RA, Jungers P, Liote F. Ischaemic necrosis of bone associated with the "lupus anticoagulant" and antibodies to cardiolipin [abstract]. In: Proceedings of the XVIth International Congress of Rheumatology, Sydney (Australia); 1985. p. 373.
42. Lavilla P., Gil A., Khamashta M.A., et al. Necrosis osea avasculary lupus eritematoso sistematico. Rev Clin Esp 181 5 (1987) 289-290
43. Nagasawa K., Ishii Y., Mayumi T., et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 48 8 (1989) 672-676
44. Mok C.C., Lau C.S., and Wong R.W. Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol 37 8 (1998) 895-900
45. Abeles M., Urman J.D., and Rothfield N.F. Aseptic necrosis of bone in systemic lupus erythematosus. Relation to corticosteroid therapy. Arch Intern Med 138 5 (1978) 750-775
46. Asherson R.A., Liote F., Page B., et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 20 2 (1993) 284-288
47. Mont M.A., Glueck C.J., Pacheco I.H., et al. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 24 4 (1997) 654-662
48. Alarcon-Segovia D., Deleze M., Oria C.V., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 68 6 (1989) 353-365
49. Pistiner M., Wallace D.J., Nessim S., et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Sem Arthritis Rheum 21 1 (1991) 55-64
50. Migliaresi S., Picillo U., Ambrosone L., et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 3 (1994) 37-41
51. Petri M. Muscosceletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 8 3 (1995) 137-145
52. Dromer C., Marc V., Laroche M., et al. No link between avascular necrosis of the femoral head and antiphospholipid antibodies. Rev Rhum Engl Ed 64 6 (1997) 382-385
53. Cozen L., and Wallace D.J. Avascular necrosis in systemic lupus erythematosus: clinical associations and a 47-year perspective. Am J Orthop 27 5 (1998) 352-354
54. Rascu A., Manger K., Kraetsch H.G., et al. Osteonecrosis in systemic lupus erythematosus, steroid induced or a lupus-dependent manifestation?. Lupus 5 4 (1996) 323-327
55. Houssiau F.A., N'Zeusseu Toukap A., Depresseux G., et al. Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies. Br J Rheumatol 37 4 (1998) 448-453
56. Mok M.Y., Farewell V.T., and Isenberg D.A. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?. Ann Rheum Dis 59 6 (2000) 462-467
57. Vela P., Battle E., Salas E., et al. Primary antiphospholipid syndrome and osteonecrosis. Clin Exp Rheumatol 9 (1991) 545-546
58. Seleznick M.J., Silveira L.H., and Espinosa L.R. Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol 18 9 (1991) 1416-1417
59. Dubost J.J., Kemeny J.L., Soubrier M., et al. Primary antiphospholipid syndrome of fatal course and osteorticular cytosteatonecrosis. Rev Med Interne 15 8 (1994) 535-540
60. Egan R.M., and Munn R.K. Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis. J Rheumatol 21 12 (1994) 2376-2379
61. Asherson R.A., Cervera R., Piette J.C., et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine 80 6 (2001) 355-377
62. Tektonidou M.G., Malagari K., Vlachoyiannopoulos P.G., et al. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum 48 3 (2003) 732-736
63. Frances C., Niang S., Laffite E., et al. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 52 6 (2005) 1785-1793
64. Hatjigeorgiou G.M., Karantanas A.H., Zibis A., et al. Increased frequency of white matter lesions in patients with osteonecrosis (WMLeOn) of the femoral head. Eur J Rad 50 3 (2004) 278-284
65. Mok M.Y., and Isenberg D.A. Avascular necrosis of a single vertebral body, an atypical site of disease in a patient with SLE and secondary APLS. Ann Rheum Dis 59 6 (2000) 494
66. Yoo W.H. Multiple rib infarcts: a rare form of osteonecrosis in antiphospholipid syndrome. Ann Rheum Dis 63 4 (2004) 457-458
67. Galindo M., Mateo I., and Pablos J.L. Multiple avascular necrosis of bone and polyarticular septic arthritis in patients with systemic lupus erythematosus. Rheumatol Int 25 1 (2005) 72-76
68. Fishel B., Caspi D., Eventov I., et al. Multiple osteonecrotic lesions in systemic lupus erythematosus. J Rheumatol 14 3 (1987) 601-604
69. Plakseychuk A.Y., Shah M., Varitimidis S.E., et al. Classification of osteonecrosis of the femoral head. Reliability, reproducibility, and prognostic value. Clin Orthop Relat Res 386 (2001) 34-41
70. Tervonen O., Mueller D.M., Matteson E.L., et al. Clinically occult avascular necrosis of the hip: prevalence in an asymptomatic population at risk. Radiology 182 3 (1992) 845-847
71. Coleman B.G., Kressel H.Y., Dalinka M.K., et al. Radiographically negative avascular necrosis: detection with MR imaging. Radiology 168 2 (1988) 525-528
72. Mont M.A., Carbone J.J., and Fairbank A.C. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Rel Res 324 (1996) 169-178
73. D' Souza S.R., Sadiq S., and Northmore-Balle M.D. Proximal femoral osteotomy as the primary operation for young adults who have osteoarthritis of the hip. J Bone Joint Surg 80A (1998) 1428-1438
74. Cornell C.N., Salvati E.A., and Pelicci P.M. Long term follow-up of total hip replacement in patients with osteonecrosis. Orthop Clin North Am 16 4 (1985) 757-769
75. Vasoo S., Sangle S., Zain M., et al. Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome. Lupus 14 5 (2005) 339-345
76. Erkan D., Leibowitz E., Berman J., et al. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature and recommendations. J Rheumatol 29 4 (2002) 843-849
77. Sangle S., D'Cruz D., Khamashta M.A., et al. Antiphospholipid antibodies, systemic lupus erythematosus and non-traumatic metatarsal fractures. Ann Rheum Dis 63 10 (2004) 1241-1243
78. Bulvik S., Aronson I., Ress S., et al. Extensive bone marrow necrosis associated with antiphospholipid antibodies. Am J Med 98 6 (1995) 572-574
79. Paydas S., Kocak R., Zorludemir S., et al. Bone marrow necrosis in antiphospholipid syndrome. J Clin Pathol 50 3 (1997) 261-262
80. Murphy P.T., Sivakumaran M., Casey M.C., et al. Lymphoma associated bone marrow necrosis with raised anticardiolipin antibody. J Clin Pathol 51 5 (1998) 407-409
81. Moore J., Ma D.D., and Concannon A. Non-malignant bone marrow necrosis: a report of two cases. Pathology 30 3 (1998) 318-320
82. Schaar C.G., Ronday K.H., Boets E.P., et al. Catastrophic manifestation of the antiphospholipid syndrome. J Rheumatol 26 10 (1999) 2261-2264
83. Thuerl C., Altehoefer C., Spyridonidis A., et al. Imaging findings in the rare catastrophic variant of the primary antiphospholipid syndrome. Eur Radiol 12 3 (2002) 545-548
84. Sinha J., Chowdhry I., Sedan S., et al. Bone marrow necrosis and refractory HELLP syndrome in a patient with catastrophic antiphospholipid antibody syndrome. J Rheumatol 29 1 (2002) 195-197